Copyright
©The Author(s) 2022.
World J Gastrointest Pathophysiol. May 22, 2022; 13(3): 96-106
Published online May 22, 2022. doi: 10.4291/wjgp.v13.i3.96
Published online May 22, 2022. doi: 10.4291/wjgp.v13.i3.96
Figure 2 Flow chart.
A: A flowchart in sorting nonalcoholic fatty liver disease (NAFLD) patients using the fibrosis-4 index, Agiles, and other fibrosis markers; B: A proposal algorithm to narrow the high-risk group of NAFLD patients with hepatocellular carcinoma and/or esophagogastric varices. HCC: Hepatocellular carcinoma; EGV: Esophagogastric varices; LSM: Liver stiffness measurement; M2BPGi: Mac2-binding protein glycosylation isomer; NAFLD: Nonalcoholic fatty liver disease.
- Citation: Miura K, Maeda H, Morimoto N, Watanabe S, Tsukui M, Takaoka Y, Nomoto H, Goka R, Kotani K, Yamamoto H. Utility of FibroScan-based scoring systems to narrow the risk group of nonalcoholic fatty liver disease with comorbidities. World J Gastrointest Pathophysiol 2022; 13(3): 96-106
- URL: https://www.wjgnet.com/2150-5330/full/v13/i3/96.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v13.i3.96